Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor M Villalobos

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Targeted Oncology|August 26, 2018
Targeted Therapies in the Treatment of SarcomasBrianna Hoffner, Anthony D Elias, Victor M Villalobos
JCO Clinical Cancer Informatics|January 18, 2019
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome AtlasVictor M Villalobos, Yan C Wang, Branimir I Sikic
Clinical Sarcoma Research|November 21, 2017
A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the USVictor M Villalobos, Stacey DaCosta Byfield, Sameer R Ghate, et al.
Biotechnology Progress|March 31, 2009
Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensorsSeth T Gammon, Victor M Villalobos, Mikhail Roshal, et al.
Bioconjugate Chemistry|March 20, 2003
Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptakeSeth T Gammon, Victor M Villalobos, Julie L Prior, et al.
Plos One|February 18, 2016
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-AnalysisScooter Willis, Victor M Villalobos, Olivier Gevaert, et al.
Molecular Imaging|June 20, 2006
Permeation peptide conjugates for in vivo molecular imaging applicationsKristin E Bullok, Seth T Gammon, Stefania Violini, et al.
Cancer Medicine|December 11, 2019
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcomaVictor M Villalobos, Gary Mo, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced ChondrosarcomaWilliam D Tap, Victor M Villalobos, Gregory M Cote, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Targeted Oncology|August 26, 2018
Targeted Therapies in the Treatment of SarcomasBrianna Hoffner, Anthony D Elias, Victor M Villalobos
JCO Clinical Cancer Informatics|January 18, 2019
Reannotation and Analysis of Clinical and Chemotherapy Outcomes in the Ovarian Data Set From The Cancer Genome AtlasVictor M Villalobos, Yan C Wang, Branimir I Sikic
Clinical Sarcoma Research|November 21, 2017
A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the USVictor M Villalobos, Stacey DaCosta Byfield, Sameer R Ghate, et al.
Biotechnology Progress|March 31, 2009
Rational design of novel red-shifted BRET pairs: Platforms for real-time single-chain protease biosensorsSeth T Gammon, Victor M Villalobos, Mikhail Roshal, et al.
Bioconjugate Chemistry|March 20, 2003
Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptakeSeth T Gammon, Victor M Villalobos, Julie L Prior, et al.
Plos One|February 18, 2016
Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-AnalysisScooter Willis, Victor M Villalobos, Olivier Gevaert, et al.
Molecular Imaging|June 20, 2006
Permeation peptide conjugates for in vivo molecular imaging applicationsKristin E Bullok, Seth T Gammon, Stefania Violini, et al.
Cancer Medicine|December 11, 2019
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcomaVictor M Villalobos, Gary Mo, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced ChondrosarcomaWilliam D Tap, Victor M Villalobos, Gregory M Cote, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Pageof 2